Connectathon 11 Snapshot
This page is part of the FHIR Specification (v1.2.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
This is a value set defined at http://healthcaresoa.org 
.
Summary
| Defining URL: | http://hl7.org/fhir/ValueSet/hspc-NarrativeLabCodes |
| Name: | HSPC Narrative Labs |
| Definition: | Ordinal LOINC codes used in HSPC |
| OID: | 2.16.840.1.113883.4.642.2.0 (for OID based terminology systems) |
| Copyright: | This content LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use |
| Source Resource | XML / JSON |
This value set is not currently used
This value set includes codes from the following code systems:
| Code | Display | |
| 1006-6 | Direct antiglobulin test.IgG specific reagent [interpretation] on Red Blood Cells | |
| 10333-3 | Appearance of Cerebral spinal fluid | |
| 10335-8 | Color of Cerebral spinal fluid | |
| 10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain | |
| 10569-2 | Color of Semen | |
| 10573-4 | Ferning [Type] in Cervical mucus | |
| 10701-1 | Ova+Parasites identified in Stool by Concentration|Ova and parasites identified in Stool by Concentration | |
| 10762-3 | Microscopic observation [Identifier] in Blood by Hemosiderin stain | |
| 11019-7 | Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain | |
| 11158-3 | Appearance of Serum | |
| 11546-9 | Microscopic observation [Identifier] in Unspecified specimen by Other stain | |
| 12286-1 | Drugs identified in Urine by Screen method | |
| 1250-0 | Major crossmatch [interpretation] | |
| 13306-6 | HLA-DR beta [Type] | |
| 13440-3 | Immunofixation [interpretation] for Urine | |
| 13501-2 | Herpes simplex virus 2 Ab pattern [interpretation] in Serum | |
| 13510-3 | Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain | |
| 14575-5 | Blood group antibody investigation [interpretation] in Plasma or RBC | |
| 14611-8 | Nuclear Ab pattern [interpretation] in Serum | |
| 14618-3 | Appearance of Stone|Appearance in Stone | |
| 14869-2 | Pathologist review of Blood tests | |
| 14884-1 | Porphyrins [interpretation] in Stool | |
| 15200-9 | Osmolality of Body fluid | |
| 16112-5 | Estrogen receptor [interpretation] in Tissue | |
| 16113-3 | Progesterone receptor [interpretation] in Tissue | |
| 16793-2 | Drugs identified in Unknown substance by Screen method | |
| 19066-0 | Blood bank comment | |
| 19144-5 | Reason for drug test [interpretation] | |
| 19146-0 | Reference lab test results | |
| 19156-9 | Susceptibility method - Unspecified specimen|Susceptibility method [Identifier] in Unspecified specimen|Susceptibility method [Identifier] | |
| 20431-3 | Microscopic observation [Identifier] in Unspecified specimen by Smear | |
| 20510-4 | Lipoprotein fractions [interpretation] in Serum or Plasma by Electrophoresis | |
| 20671-4 | Amino acids [interpretation] in Serum or Plasma|Deprecated Amino acids [interpretation] in Serum or Plasma | |
| 20785-2 | Drugs identified in Serum or Plasma by Screen method | |
| 20787-8 | Drugs identified in Unspecified specimen by Screen method | |
| 20990-8 | APC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 21299-3 | Gestational age method | |
| 21412-2 | Myocardium Ab pattern [interpretation] in Serum | |
| 21667-1 | F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 27034-8 | Drugs identified in Hair by Screen method | |
| 29495-9 | Herpes virus 6 DNA [Presence] in Unspecified specimen by Probe and target amplification method|Herpes virus 6 DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 30554-0 | HIV reverse transcriptase gene mutations detected [Identifier] in Isolate|HIV reverse transcriptase gene mutations detected [Identifier] | |
| 30934-4 | Natriuretic peptide B [Mass/volume] in Serum or Plasma | |
| 31208-2 | Specimen source [Identifier] of Unspecified specimen | |
| 3152-6 | Inhaled oxygen mechanism Dose | |
| 31868-3 | Legionella pneumophila 1 Ag [Presence] in Urine | |
| 32286-7 | Hepatitis C virus genotype [Identifier] in Serum or Plasma by Probe and target amplification method|Hepatitis C virus genotype [Identifier] in Serum or Plasma by Probe and target amplification method | |
| 32297-4 | Amino acids [interpretation] in Urine|Deprecated Amino acids [interpretation] in Urine | |
| 32624-9 | Race | |
| 32700-7 | Microscopic observation [Identifier] in Blood by Malaria smear | |
| 32769-2 | Alpha 1 antitrypsin phenotyping [interpretation] in Serum or Plasma | |
| 33050-6 | Pseudocholinesterase phenotype [Identifier] in Serum or Plasma | |
| 33271-8 | Microscopic observation [Identifier] in Blood by Malaria thin smear | |
| 33511-7 | Appearance of Unspecified specimen | |
| 33630-5 | HIV protease gene mutations detected [Identifier] in Isolate|HIV protease gene mutations detected [Identifier] | |
| 34474-7 | ABO + Rh group [Type] in Cord blood|ABO and Rh group [Type] in Cord blood|ABO and Rh group [Type] in Cord blood | |
| 34477-0 | Blood group antibodies present [Identifier] in Serum or Plasma by Elution | |
| 34478-8 | Blood group antibodies present [Identifier] in Blood by Chromogenic method | |
| 34479-6 | Blood group antibodies present [Identifier] in Serum or Plasma by Cold absorption | |
| 34480-4 | Blood group antibodies present [Identifier] in Serum or Plasma by Cold incubation | |
| 34481-2 | Blood group antibodies present [Identifier] in Serum or Plasma by Warm incubation | |
| 34482-0 | Blood group antibodies present [Identifier] in Serum or Plasma by Warm absorption | |
| 34959-7 | Microscopic observation [Identifier] in Blood by Myeloperoxidase stain | |
| 34960-5 | HLA Ab [Identifier] | |
| 34961-3 | Rh [Type] in Blood by Confirmatory method | |
| 34964-7 | Osmotic fragility [interpretation] of Red Blood Cells | |
| 38348-9 | Herpes virus 6 DNA [Identifier] in Unspecified specimen by Probe and target amplification method|Herpes virus 6 DNA [Identifier] in Unspecified specimen by Probe and target amplification method | |
| 41048-0 | TPMT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 41273-4 | Alpha-1-Fetoprotein interpretation [interpretation] in Amniotic fluid | |
| 41274-2 | Alpha-1-Fetoprotein interpretation [interpretation] in Serum or Plasma | |
| 42675-9 | HLA Ag [interpretation] | |
| 43284-9 | Spermatozoa IgA binding location [Identifier] in Semen | |
| 43287-2 | Spermatozoa IgG binding location [Identifier] in Semen | |
| 43370-6 | CFTR gene p.IVS8 PolyT [Presence] in Blood or Tissue by Molecular genetics method | |
| 43804-4 | Amino acids [interpretation] in Cerebral spinal fluid|Amino acid pattern [interpretation] in Cerebral spinal fluid | |
| 44014-9 | Porphyrins [interpretation] in Urine | |
| 44074-3 | Arbovirus Ab [interpretation] in Serum by Immunofluorescence | |
| 4465-1 | Hamster Ova Penetration Test [interpretation] in Semen | |
| 44838-1 | Catecholamines [interpretation] in Plasma | |
| 45175-7 | HIV nucleoside reverse transcriptase gene mutations detected [Identifier] in Isolate|HIV nucleoside reverse transcriptase gene mutations detected [Identifier] | |
| 45176-5 | HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier] in Isolate|HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier] | |
| 47938-6 | Specimen source [Identifier] of Body fluid | |
| 48818-9 | Karyotype [Identifier] in Blood or Tissue by High resolution Nominal | |
| 49024-3 | Differential cell count method - Blood|Differential cell count method [Type] in Blood | |
| 49541-6 | Fasting status [Presence] - Reported|Fasting status - Reported | |
| 50008-2 | Mixing studies [interpretation] in Platelet poor plasma Narrative | |
| 50595-8 | Pathologist interpretation of Unspecified specimen tests | |
| 50722-8 | VKORC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 55192-9 | Chromosome analysis.interphase [interpretation] in Amniotic fluid by Fluorescent in situ hybridization (FISH) Narrative | |
| 56164-7 | CYP2C9 gene allele 2 [Identifier] in Blood by Molecular genetics method Nominal | |
| 56165-4 | CYP2C9 gene allele 3 [Identifier] in Blood by Molecular genetics method Nominal | |
| 5767-9 | Appearance of Urine | |
| 5778-6 | Color of Urine | |
| 5779-4 | Crystals [type] in Bile fluid by Light microscopy | |
| 5781-0 | Crystals [type] in Synovial fluid by Light microscopy | |
| 5909-7 | Blood smear finding [Identifier] in Blood by Light microscopy | |
| 59465-5 | Pathologist review [interpretation] in Unspecified specimen Narrative|Pathologist review of results | |
| 6013-7 | von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot (IB) | |
| 6262-0 | Swine epithelium IgE Ab [Units/volume] in Serum | |
| 62862-8 | Microsatellite instability [Presence] in Tissue by Immune stain | |
| 63558-1 | HLA-DQB1*0602 [Presence] | |
| 637-9 | Microscopic observation [Identifier] in Blood by Malaria thick smear | |
| 64013-6 | Escherichia coli shiga-like toxin 1 and 2 Ag [Identifier] in Stool by Immunoassay | |
| 675-9 | Enterobius vermicularis [Presence] in Unspecified specimen by Pinworm exam|Enterobius vermicularis [Presence] in Unspecified specimen Qualitative by Pinworm exam|Enterobius vermicularis [Identifier] in Unspecified specimen by Pinworm exam | |
| 6824-7 | Color of Body fluid | |
| 6825-4 | Crystals [type] in Body fluid by Light microscopy | |
| 881-3 | ABO + Rh group [Type] in Serum or Plasma from Blood product unit|ABO and Rh group [Type] in Serum or Plasma from Blood product unit|ABO and Rh group [Type] in Serum or Plasma from Blood product unit | |
| 882-1 | ABO + Rh group [Type] in Blood|ABO and Rh group [Type] in Blood|ABO and Rh group [Type] in Blood | |
| 883-9 | ABO group [Type] in Blood | |
| 888-8 | Blood group antibodies identified in Serum or Plasma | |
| 906-8 | Blood group antigens present [Identifier] in Blood | |
| 9109-0 | Blood loss.total intraoperative [Volume] Cell saver | |
| 9194-2 | Type of Urine collection method | |
| 925-8 | Blood product disposition [Type] | |
| 927-4 | Blood product.pooled [Identifier] | |
| 933-2 | Blood product type | |
| 9335-1 | Appearance of Body fluid | |
| 9409-4 | Anabolic steroids [Identifier] in Urine | |
| 9785-7 | Microscopic observation [Identifier] in Stool by Ova and Parasite Preparation|Deprecated Microscopic observation [Identifier] in Stool by Ova and Parasite Preparation | |
| 9795-6 | Composition in Stone | |
| 66759-2 | Heparin neutralization [Presence] in Blood by Thromboelastography |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
© HL7.org 2011+. FHIR DSTU2 (v1.2.0-7447) generated on Fri, Dec 11, 2015 17:40+1100.
Links: Search |
Version History |
Table of Contents |
Compare to DSTU1 |
|
Propose a change